Artificial intelligence for the evaluation of movements in DMD

Partager sur

Clinical trials using force or movement measurements are highly dependent on patient motivation. To overcome this bias, British researchers developed a biomedical device with whole-body motion sensors to measure kinetic activity in real life:

  • 21 patients with Duchenne muscular dystrophy (DMD) participated in the study,
  • 18 were still ambulant versus three non-ambulant,
  • the data obtained were compared to those of a population of 17 healthy volunteers,
  • The experiment lasted one year.

The authors developed a behavioral biomarker called “KineDMDethomic” and defined specific trajectories for each patient with DMD.

 

Wearable full-body motion tracking of activities of daily living predicts disease trajectory in Duchenne muscular dystrophy. Ricotti V, Kadirvelu B, Selby V et al. Nat Med. 2023 Jan;29(1):95-103.

On the same topic